MMedication Read More Daraxonrasib shrinks tumours in one-third of lung cancer patientsSeptember 4, 2026 Revolution Medicines Inc. (NASDAQ: RVMD) has reported encouraging lung cancer results for its experimental cancer pill daraxonrasib. The…